Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.54 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.54 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.54 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.54 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.49 |
| ▸ | P2RY2 | P41231 | 5/20 | 0.48 |
| ▸ | P2RY6 | Q15077 | 4/20 | 0.48 |
| ▸ | P2RY4 | P51582 | 3/20 | 0.48 |
| ▸ | PYGM | P11217 | 3/20 | 0.41 |
| ▸ | TK2 | O00142 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | MTOR | P42345 | 1/20 | 0.39 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.39 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.39 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4474459 | 0.89 | SLC28A1 (0.70) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL4474462 | 0.89 | SLC28A1 (0.70) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL21418839 | 0.83 | SLC28A1 (0.61) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL34578 | 0.83 | SLC28A1 (0.76) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL329270 | 0.83 | SLC28A1 (0.76) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL9057418 | 0.83 | SLC28A1 (0.76) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL6672543 | 0.83 | SLC28A1 (0.76) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL21418661 | 0.83 | SLC28A1 (0.76) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL34577 | 0.83 | SLC28A1 (0.76) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL14544181 | 0.83 | SLC28A1 (0.76) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8841428-B2 | Polynucleotide nanomechanical device that acts as an artificial ribosome and translates DNA signals into polymer assembly instructions | NEW YORK UNIVERSITY (US) | 2014-09-23 | — | — | US | disclosed |
| US-7943751-B2 | Ladder copolymers | NEW YORK UNIVERSITY (US) | 2011-05-17 | — | — | US | disclosed |
| US-20090137738-A1 | LADDER COPOLYMERS | NEW YORK UNIVERSITY (US) | 2009-05-28 | — | — | US | disclosed |
| US-7479548-B1 | Nucleic acid based ladder copolymers | NEW YORK UNIVERSITY (US) | 2009-01-20 | — | — | US | disclosed |
| US-20090005329-A1 | NUCLEIC ACID BASED LADDER COPOLYMERS | NEW YORK UNIVERSITY (US) | 2009-01-01 | — | — | US | disclosed |
| WO-2008127453-A2 | NUCLEIC ACID-BASED TRANSLATION SYSTEM AND METHOD FOR DECODING NUCLEIC ACID ENCRYPTED MESSAGE | GARIBOTTI ALEJANDRA V (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080221315-A1 | NUCLEIC ACID-BASED TRANSLATION SYSTEM AND METHOD FOR DECODING NUCLEIC ACID ENCRYPTED MESSAGE | NEW YORK UNIVERSITY (US) | 2008-09-11 | — | — | US | disclosed |
| WO-2006017432-A2 | A POLYNUCLEOTIDE NANOMECHANICAL DEVICE THAT ACTS AS AN ARTIFICIAL RIBOSOME AND TRANSLATES DNA SIGNALS INTO POLYMER ASSEMBLY INSTRUCTIONS | NEW YORK UNIVERSITY (US) | 2006-02-16 | — | — | WO | disclosed |
| US-20060035255-A1 | Polynucleotide nanomechanical device that acts as an artificial ribosome and translates DNA signals into polymer assembly instructions | NEW YORK UNIVERSITY (US) | 2006-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080221315-A1 | NUCLEIC ACID-BASED TRANSLATION SYSTEM AND METHOD FOR DECODING NUCLEIC ACID ENCRYPTED MESSAGE | NSUN3, RNMT, RNGTT | SLC28A1 929/4885SLC28A2 717/4885SLC29A1 672/4885 |
| US-20090005329-A1 | NUCLEIC ACID BASED LADDER COPOLYMERS | POLL, POLM, POLRMT | SLC28A1 2924/4885SLC28A2 3100/4885SLC29A1 876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.